Clinical trial
Stem Cell Transplantation for Patients With Hematologic Malignancies
NCT00152139 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00152139 |
|---|---|
| Title | Stem Cell Transplantation for Patients With Hematologic Malignancies |
| Official title | Hematopoietic Stem Cell Transplantation Using Matched Unrelated Donor Peripheral Blood or Bone Marrow for Patients With Hematologic Malignancies |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemias, Acute Myelocytic Leukemia, Chronic Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Hemoglobinuria, Paroxysmal, Non-Hodgkin Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | Allogeneic Stem Cell Transplantation, Chemotherapy and antibodies |
| Enrollment | 33 |
| Start date | May 1, 2002 |
| Primary completion | Jun 1, 2005 |
| Completion | Jan 1, 2009 |
| First posted | Sep 9, 2005 |
| Last update posted | Jan 29, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: